Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

The impact of patient personality traits on adherence to tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Publication Information:
      eScholarship, University of California
    • Publication Date:
      2025
    • Collection:
      University of California: eScholarship
    • Subject Terms:
      4638 - 4638
    • Abstract:
      Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm driven by the BCR::ABL1 fusion oncoprotein and treated with oral tyrosine kinase inhibitors (TKIs), which have significantly improved long-term survival. However, sustained therapeutic response is closely tied to patient adherence, with suboptimal adherence linked to inferior molecular and clinical outcomes. Despite known barriers to adherence, including side effects, cost, and disease-related distress, little is known about the role of patient personality traits in influencing adherence behavior, particularly among patients with CML. To address this gap, we conducted a prospective pilot study evaluating the relationship between patient personality traits, medication adherence, and quality of life among individuals with CML receiving TKI therapy. Subjects were recruited from the University of California, Irvine Chao Family Comprehensive Cancer Center and the CML Buster Foundation national patient network. Eligible patients were adults (18 years of age and older) with chronic-phase CML on one of six FDA-approved TKIs: imatinib, dasatinib, bosutinib, nilotinib, ponatinib, or asciminib. A total of 42 English and Spanish speaking subjects completed structured interviews, which included the 8-item Morisky Medication Adherence Scale (MMAS-8), the 20-item International Personality Item Pool (Mini-IPIP) Five Factor Model personality inventory, and the European Organization of Research and Treatment of Cancer Quality of Life Questionnaire for Chronic Myeloid Leukemia-24 (EORTC QLQ-CML24). MMAS-8 scores were used to categorize patients into high (n=12, 28.57%), medium (n=18, 42.86%), and low (n=12, 28.57%) adherence groups. Personality trait scores and QLQ-CML24 raw scores were analyzed across adherence groups using one-way ANOVA or Kruskal-Wallis tests as appropriate per Shapiro-Wilk test (alpha=0.05). Among the Five Factor Model traits (openness, conscientiousness, extraversion, agreeableness, and neuroticism), only neuroticism significantly ...
    • File Description:
      application/pdf
    • Relation:
      qt8g8892jp; https://escholarship.org/uc/item/8g8892jp; https://escholarship.org/content/qt8g8892jp/qt8g8892jp.pdf
    • Accession Number:
      10.1182/blood-2025-4638
    • Online Access:
      https://escholarship.org/uc/item/8g8892jp
      https://escholarship.org/content/qt8g8892jp/qt8g8892jp.pdf
      https://doi.org/10.1182/blood-2025-4638
    • Rights:
      public
    • Accession Number:
      edsbas.266C5E03